The PREVAiLS study will be conducted at up to 60 ALS centres throughout 13 countries.

PREVAiLS is a pivotal, global, 500-participant Phase 3 study to evaluate efficacy and safety of pridopidine, an investigational drug, in slowing ALS progression (ALSFRS-R) in early, rapidly ...

Motor Neurone Disease is a devastating condition that targets the nerves controlling movement, causing muscles to cease ...

Belfast actor Michael Campbell, also known as Michael Patrick, was diagnosed with the condition in February 2023. On April 8, ...

Early symptoms might not appear serious but should be checked by your doctor regardless ...

A hallmark sign of MND is 'foot drop', a condition arising from muscle weakness that hinders the ability to lift the front ...

Add Yahoo as a preferred source to see more of our stories on Google. There could be new hope for ALS management as a promising drug enters phase 3 clinical trials. ALS is a progressive disease in ...

There could be new hope for ALS management as a promising drug enters phase 3 clinical trials. ALS is a progressive disease in which the brain loses connection with the muscles, The ALS Association ...

A new study reveals that gut bacteria may play a key role in triggering ALS and frontotemporal dementia. Harmful sugars ...

It’s well established that some cases of amyotrophic lateral sclerosis (ALS) are caused by mutations that are inherited from a person’s parents — but a new study shows some cases of sporadic ALS may ...

Every few months for the past three years, Jeff Vierstra has been receiving infusions in his spine that target and disable a mutated gene that made it likely he would develop ALS.